| RS2509964271 |
SLC4A1
|
Health Risk |
Likely pathogenic |
— |
| RS2509965507 |
SLC4A1
|
Health Risk |
Likely pathogenic |
SLC4A1-related disorder, SLC4A1-related disorder |
| RS2509965514 |
SLC4A1
|
Health Risk |
Pathogenic |
— |
| RS2509965517 |
SLC4A1
|
Health Risk |
Pathogenic |
— |
| RS2509965970 |
SLC4A1
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS2509966036 |
SLC4A1
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS2509966235 |
SLC4A1
|
Health Risk |
Likely pathogenic |
— |
| RS2509966486 |
SLC4A1
|
Health Risk |
Pathogenic |
Hereditary spherocytosis type 4, Hereditary spherocytosis type 4 |
| RS2509966572 |
SLC4A1
|
Health Risk |
Likely pathogenic |
SLC4A1-related disorder, SLC4A1-related disorder |
| RS2509966665 |
SLC4A1
|
Health Risk |
Pathogenic |
— |
| RS2509966742 |
SLC4A1
|
Health Risk |
Likely pathogenic |
— |
| RS2509967246 |
SLC4A1
|
Health Risk |
Likely pathogenic |
— |
| RS2509967323 |
SLC4A1
|
Health Risk |
Pathogenic |
— |
| RS2509967374 |
SLC4A1
|
Health Risk |
Likely pathogenic |
— |
| RS2509967379 |
SLC4A1
|
Health Risk |
Likely pathogenic |
— |
| RS2509967589 |
SLC4A1
|
Health Risk |
Likely pathogenic |
— |
| RS2509968215 |
SLC4A1
|
Health Risk |
Likely pathogenic |
— |
| RS2509968342 |
SLC4A1
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS2509968418 |
SLC4A1
|
Health Risk |
Likely pathogenic |
— |
| RS2509968499 |
SLC4A1
|
Health Risk |
Likely pathogenic |
SLC4A1-related disorder, SLC4A1-related disorder |
| RS2509968558 |
SLC4A1
|
Health Risk |
Pathogenic |
— |
| RS2509968564 |
SLC4A1
|
Health Risk |
Likely pathogenic |
— |
| RS2509969653 |
SLC4A1
|
Health Risk |
Likely pathogenic |
— |
| RS2509969702 |
SLC4A1
|
Health Risk |
Pathogenic |
— |
| RS2509970675 |
SLC4A1
|
Health Risk |
Pathogenic |
— |
| RS2509970932 |
SLC4A1
|
Health Risk |
Likely pathogenic |
— |
| RS2509970954 |
SLC4A1
|
Health Risk |
Likely pathogenic |
— |
| RS2509971147 |
SLC4A1
|
Health Risk |
Likely pathogenic |
— |
| RS2509971425 |
SLC4A1
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS2509971762 |
SMCHD1
|
Health Risk |
Pathogenic |
Facioscapulohumeral muscular dystrophy 2, Facioscapulohumeral muscular dystrophy 2 |
| RS2509972400 |
SLC4A1
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS2509973787 |
SLC4A1
|
Health Risk |
Pathogenic |
— |
| RS2509973964 |
SLC4A1
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS2509974050 |
SMCHD1
|
Health Risk |
Likely pathogenic |
— |
| RS2509993138 |
ATP6V0A1
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy 104, Developmental and epileptic encephalopathy 104 |
| RS2510021670 |
SMCHD1
|
Health Risk |
Pathogenic |
Facioscapulohumeral muscular dystrophy 2, Facioscapulohumeral muscular dystrophy 2 |
| RS2510021968 |
SMCHD1
|
Health Risk |
Pathogenic |
Facioscapulohumeral muscular dystrophy 2, Facioscapulohumeral muscular dystrophy 2 |
| RS2510027769 |
SMCHD1
|
Health Risk |
Pathogenic |
Facioscapulohumeral muscular dystrophy 2, Facioscapulohumeral muscular dystrophy 2 |
| RS2510028167 |
SMCHD1
|
Health Risk |
Likely pathogenic |
Facioscapulohumeral muscular dystrophy 2, Facioscapulohumeral muscular dystrophy 2 |
| RS2510032473 |
TGIF1
|
Health Risk |
Likely pathogenic |
Holoprosencephaly 4, Holoprosencephaly 4 |
| RS2510034129 |
SMCHD1
|
Health Risk |
Likely pathogenic |
Facioscapulohumeral muscular dystrophy 2, Facioscapulohumeral muscular dystrophy 2 |
| RS2510041967 |
SMCHD1
|
Health Risk |
Pathogenic/Likely pathogenic |
Facioscapulohumeral muscular dystrophy 2, Facioscapulohumeral muscular dystrophy 2 |
| RS2510043843 |
TGIF1
|
Health Risk |
Likely pathogenic |
Holoprosencephaly 4, Holoprosencephaly 4 |
| RS2510045525 |
PCYT2
|
Health Risk |
Likely pathogenic |
Spastic paraplegia 82, autosomal recessive |
| RS2510045920 |
TGIF1
|
Health Risk |
Pathogenic |
Holoprosencephaly 4, Holoprosencephaly 4 |
| RS2510046143 |
TGIF1
|
Health Risk |
Likely pathogenic |
— |
| RS2510047496 |
PCYT2
|
Health Risk |
Likely pathogenic |
Spastic paraplegia 82, autosomal recessive |
| RS2510047822 |
MYH11
|
Health Risk |
Conflicting classifications of pathogenicity |
Aortic aneurysm, familial thoracic 4 |
| RS2510054161 |
GRN
|
Health Risk |
Pathogenic |
Neuronal ceroid lipofuscinosis 11, GRN-related frontotemporal lobar degeneration with Tdp43 inclusions |
| RS2510054302 |
GRN
|
Health Risk |
Pathogenic |
Neuronal ceroid lipofuscinosis 11, GRN-related frontotemporal lobar degeneration with Tdp43 inclusions |
| RS2510054318 |
GRN
|
Health Risk |
Pathogenic |
GRN-related frontotemporal lobar degeneration with Tdp43 inclusions, Neuronal ceroid lipofuscinosis 11 |
| RS2510054336 |
GRN
|
Health Risk |
Likely pathogenic |
GRN-related frontotemporal lobar degeneration with Tdp43 inclusions, GRN-related frontotemporal lobar degeneration with Tdp43 inclusions |
| RS2510054484 |
GRN
|
Health Risk |
Pathogenic |
GRN-related frontotemporal lobar degeneration with Tdp43 inclusions, Neuronal ceroid lipofuscinosis 11 |
| RS2510054566 |
GRN
|
Health Risk |
Pathogenic |
GRN-related frontotemporal lobar degeneration with Tdp43 inclusions, Neuronal ceroid lipofuscinosis 11 |
| RS2510054675 |
GRN
|
Health Risk |
Likely pathogenic |
Neuronal ceroid lipofuscinosis 11, GRN-related frontotemporal lobar degeneration with Tdp43 inclusions |
| RS2510054676 |
GRN
|
Health Risk |
Pathogenic |
Neuronal ceroid lipofuscinosis 11, GRN-related frontotemporal lobar degeneration with Tdp43 inclusions |
| RS2510054721 |
GRN
|
Health Risk |
Pathogenic |
GRN-related frontotemporal lobar degeneration with Tdp43 inclusions, Neuronal ceroid lipofuscinosis 11 |
| RS2510054791 |
GRN
|
Health Risk |
Pathogenic |
GRN-related disorder, GRN-related disorder |
| RS2510055303 |
GRN
|
Health Risk |
Pathogenic |
GRN-related frontotemporal lobar degeneration with Tdp43 inclusions, Neuronal ceroid lipofuscinosis 11 |
| RS2510055566 |
GRN
|
Health Risk |
Pathogenic |
GRN-related frontotemporal lobar degeneration with Tdp43 inclusions, Neuronal ceroid lipofuscinosis 11 |
| RS2510055635 |
GRN
|
Health Risk |
Likely pathogenic |
GRN-related frontotemporal lobar degeneration with Tdp43 inclusions, GRN-related frontotemporal lobar degeneration with Tdp43 inclusions |
| RS2510055662 |
GRN
|
Health Risk |
Pathogenic |
— |
| RS2510056360 |
GRN
|
Health Risk |
Pathogenic |
Neuronal ceroid lipofuscinosis 11, GRN-related frontotemporal lobar degeneration with Tdp43 inclusions |
| RS2510056456 |
GRN
|
Health Risk |
Pathogenic |
GRN-related frontotemporal lobar degeneration with Tdp43 inclusions, Neuronal ceroid lipofuscinosis 11 |
| RS2510057012 |
CYBC1
|
Health Risk |
Pathogenic |
— |
| RS2510057150 |
GRN
|
Health Risk |
Likely pathogenic |
GRN-related frontotemporal lobar degeneration with Tdp43 inclusions, Neuronal ceroid lipofuscinosis 11 |
| RS2510057200 |
GRN
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2510057422 |
GRN
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2510057446 |
GRN
|
Health Risk |
Pathogenic |
GRN-related frontotemporal lobar degeneration with Tdp43 inclusions, Neuronal ceroid lipofuscinosis 11 |
| RS2510057451 |
GRN
|
Health Risk |
Pathogenic |
Neuronal ceroid lipofuscinosis 11, GRN-related frontotemporal lobar degeneration with Tdp43 inclusions |
| RS2510057852 |
GRN
|
Health Risk |
Pathogenic |
GRN-related frontotemporal lobar degeneration with Tdp43 inclusions, Neuronal ceroid lipofuscinosis 11 |
| RS2510057977 |
GRN
|
Health Risk |
Pathogenic |
GRN-related frontotemporal lobar degeneration with Tdp43 inclusions, Neuronal ceroid lipofuscinosis 11 |
| RS2510058230 |
GRN
|
Health Risk |
Pathogenic |
GRN-related disorder, GRN-related disorder |
| RS2510058297 |
GRN
|
Health Risk |
Pathogenic |
Neuronal ceroid lipofuscinosis 11, GRN-related frontotemporal lobar degeneration with Tdp43 inclusions |
| RS2510059044 |
LAMA1
|
Health Risk |
Likely pathogenic |
Ataxia - intellectual disability - oculomotor apraxia - cerebellar cysts syndrome, Ataxia - intellectual disability - oculomotor apraxia - cerebellar cysts syndrome |
| RS2510059095 |
LAMA1
|
Health Risk |
Likely pathogenic |
Ataxia - intellectual disability - oculomotor apraxia - cerebellar cysts syndrome, Ataxia - intellectual disability - oculomotor apraxia - cerebellar cysts syndrome |
| RS2510061846 |
SMCHD1
|
Health Risk |
Pathogenic |
SMCHD1-related disorder, SMCHD1-related disorder |
| RS2510061859 |
SMCHD1
|
Health Risk |
Pathogenic |
Facioscapulohumeral muscular dystrophy 2, Facioscapulohumeral muscular dystrophy 2 |
| RS2510067452 |
LAMA1
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2510067521 |
LAMA1
|
Health Risk |
Pathogenic |
Ataxia - intellectual disability - oculomotor apraxia - cerebellar cysts syndrome, Ataxia - intellectual disability - oculomotor apraxia - cerebellar cysts syndrome |
| RS2510069921 |
LAMA1
|
Health Risk |
Pathogenic |
— |
| RS2510070728 |
ITGA2B
|
Health Risk |
Likely pathogenic |
Glanzmann thrombasthenia, Glanzmann thrombasthenia |
| RS2510070789 |
ITGA2B
|
Health Risk |
Pathogenic |
Glanzmann thrombasthenia, Glanzmann thrombasthenia |
| RS2510072374 |
ITGA2B
|
Health Risk |
Pathogenic |
Glanzmann thrombasthenia, Glanzmann thrombasthenia |
| RS2510072662 |
ITGA2B
|
Health Risk |
Pathogenic |
Glanzmann thrombasthenia, Glanzmann thrombasthenia |
| RS2510073184 |
ITGA2B
|
Health Risk |
Likely pathogenic |
Glanzmann thrombasthenia, Glanzmann thrombasthenia |
| RS2510073256 |
LAMA1
|
Health Risk |
Pathogenic |
— |
| RS2510073844 |
LAMA1
|
Health Risk |
Pathogenic |
Ataxia - intellectual disability - oculomotor apraxia - cerebellar cysts syndrome, Ataxia - intellectual disability - oculomotor apraxia - cerebellar cysts syndrome |
| RS2510074137 |
ITGA2B
|
Health Risk |
Pathogenic |
Glanzmann thrombasthenia, Glanzmann thrombasthenia |
| RS2510074434 |
LAMA1
|
Health Risk |
Likely pathogenic |
— |
| RS2510074733 |
ITGA2B
|
Health Risk |
Likely pathogenic |
Glanzmann thrombasthenia, Glanzmann thrombasthenia |
| RS2510074739 |
ITGA2B
|
Health Risk |
Pathogenic |
Glanzmann thrombasthenia, Glanzmann thrombasthenia |
| RS2510074785 |
ITGA2B
|
Health Risk |
Pathogenic |
Glanzmann thrombasthenia, Glanzmann thrombasthenia |
| RS2510074983 |
ITGA2B
|
Health Risk |
Pathogenic |
Glanzmann thrombasthenia, Glanzmann thrombasthenia |
| RS2510075036 |
ITGA2B
|
Health Risk |
Pathogenic |
Glanzmann thrombasthenia, Glanzmann thrombasthenia |
| RS2510075075 |
ITGA2B
|
Health Risk |
Pathogenic |
Glanzmann thrombasthenia, Glanzmann thrombasthenia |
| RS2510075915 |
ITGA2B
|
Health Risk |
Pathogenic |
Glanzmann thrombasthenia, Glanzmann thrombasthenia |
| RS2510077415 |
CYBC1
|
Health Risk |
Pathogenic |
— |
| RS2510077481 |
ITGA2B
|
Health Risk |
Pathogenic |
Glanzmann thrombasthenia, Glanzmann thrombasthenia |
| RS2510077579 |
ITGA2B
|
Health Risk |
Pathogenic |
Glanzmann thrombasthenia, Glanzmann thrombasthenia |